3 Results for "

Azeloprazole

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Azeloprazole" in MCE Product Catalog:

Cat. No.: HY-109023
CAS No.: 955095-45-1
Target:  

Na+/K+ ATPase

Research Areas:  

Inflammation/Immunology

Azeloprazole is an orally active proton pump inhibitor. Azeloprazole irreversibly binds to and blocks the proton pump (H +/K +-ATPase) on parietal cells, thereby inhibiting gastric acid secretion. Azeloprazole is primarily metabolized by the CYP3A4 enzyme, and its pharmacokinetics and acid-suppressive effects are independent of CYP2C19 activity. Azeloprazole can be used for research on acid-related diseases such as reflux esophagitis and gastroesophageal reflux disease .
loading...
    loading...
Cat. No.: HY-19865
CAS No.: 955095-47-3
Target:  

Na+/K+ ATPase

Research Areas:  

Inflammation/Immunology

Azeloprazole sodium is an orally active proton pump inhibitor. Azeloprazole sodium irreversibly binds to and blocks the proton pump (H +/K +-ATPase) on parietal cells, thereby inhibiting gastric acid secretion. Azeloprazole sodium is primarily metabolized by the CYP3A4 enzyme, and its pharmacokinetics and acid-suppressive effects are independent of CYP2C19 activity. Azeloprazole sodium can be used for research on acid-related diseases such as reflux esophagitis and gastroesophageal reflux disease .
loading...
    loading...
Cat. No.: HY-109023A
CAS No.: 955095-50-8
Target:  

Na+/K+ ATPase

Research Areas:  

Inflammation/Immunology

Azeloprazole potassium is an orally active proton pump inhibitor. Azeloprazole potassium irreversibly binds to and blocks the proton pump (H +/K +-ATPase) on parietal cells, thereby inhibiting gastric acid secretion. Azeloprazole potassium is primarily metabolized by the CYP3A4 enzyme, and its pharmacokinetics and acid-suppressive effects are independent of CYP2C19 activity. Azeloprazole potassium can be used for research on acid-related diseases such as reflux esophagitis and gastroesophageal reflux disease .
loading...
    loading...